Literature DB >> 13276902

Clinical experience with phenylindanedione (danilone) with special reference to dosage.

R E BEAMISH, S A CARTER.   

Abstract

Entities:  

Keywords:  PHENINDIONE/dosage

Mesh：

Substances：

Year:  1956        PMID： 13276902      PMCID： PMC1826394     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  The clinical evaluation of phenylindandione as an anticoagulant.

Authors:  O R KRUESI; F J SCHILLING
Journal:  N Engl J Med       Date:  1954-12-02       Impact factor: 91.245

2.  Clinical use of a new anticoagulant, phenylindanedione; report of 400 cases.

Authors:  A BLAUSTEIN; N SHNAYERSON; R WALLACH
Journal:  Am J Med       Date:  1953-06       Impact factor: 4.965

3.  The anticoagulant effect of phenylindanedione in thromboembolic disorders.

Authors:  K W G BROWN; R L MACMILLAN
Journal:  Am J Med Sci       Date:  1953-05       Impact factor: 2.378

4.  Clinical use of the anticoagulant phenylindanedione; report of 74 cases.

Authors:  F W PRESTON; W R O'CONNOR; C E THOMPSON; E N CHRISTENSEN
Journal:  Circulation       Date:  1952-10       Impact factor: 29.690

5.  Experience with the new anticoagulant phenylindanedione in acute myocardial infarction; preliminary report of 50 cases.

Authors:  W R O'CONNOR; C E THOMPSON; L A BAKER
Journal:  Q Bull Northwest Univ Med Sch       Date:  1952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.